NAC and SS-31 Shield Lungs from Ozone Damage via Oxidative and Inflammatory Pathways
Two antioxidants block ozone-triggered airway inflammation and mucus overproduction by targeting mitochondrial ROS and PI3K/AKT signaling.
Summary
Ozone exposure is a growing environmental health concern that triggers acute airway damage through oxidative stress and inflammation — processes that accelerate with aging. This mouse study compared two antioxidants: N-acetylcysteine (NAC), a widely used supplement, and SS-31 (Elamipretide), a newer mitochondria-targeted peptide. Both were given before ozone exposure and both significantly reduced airway hyperresponsiveness, inflammatory cell infiltration, and excess mucus production. Mechanistically, they worked by lowering reactive oxygen species — including those generated specifically within mitochondria — and by suppressing two key inflammatory signaling cascades: PI3K/AKT and NLRP3/caspase-1/GSDMD (a pyroptosis pathway). The results suggest that protecting mitochondria from oxidative stress may be a particularly promising strategy for limiting ozone-induced lung injury, with implications for aging populations who are most vulnerable to air pollution.
Detailed Summary
Air pollution, particularly ozone, poses serious risks to respiratory health and is increasingly recognized as a driver of age-accelerating inflammation. Older adults are disproportionately vulnerable to ozone-induced lung injury, making protective strategies highly relevant to the longevity field. This study investigated whether two antioxidants — the well-known supplement N-acetylcysteine (NAC) and the mitochondria-targeted peptide Elamipretide (SS-31) — could prevent acute ozone-induced airway damage and the biological mechanisms involved.
Researchers exposed C57BL/6J mice to a single high dose of ozone after pretreating them with either NAC or SS-31. They then assessed airway hyperresponsiveness (AHR), bronchoalveolar lavage inflammatory cells, mucus and mucin (MUC5B) production, oxidative stress markers, and activation of PI3K/AKT and NLRP3 inflammatory pathways. Parallel experiments in human airway epithelial cells (BEAS-2B) confirmed in vitro findings.
Both NAC and SS-31 comparably reduced ozone-induced airway hyperresponsiveness and mucus hypersecretion. They restored redox balance by decreasing total and mitochondrial ROS, lowering malondialdehyde (a lipid peroxidation marker), boosting superoxide dismutase activity, and improving the GSH/GSSG ratio. Critically, both agents suppressed activation of PI3K/AKT signaling and the downstream NLRP3/caspase-1/GSDMD pyroptosis pathway. A selective PI3K inhibitor replicated these protective effects in vitro, confirming PI3K/AKT as a central mechanistic node.
These findings are significant for longevity science because mitochondrial dysfunction and chronic low-grade inflammation (inflammaging) are hallmarks of biological aging. SS-31 specifically targets mitochondria, suggesting that mitochondria-directed antioxidant therapy may offer targeted protection against environmentally triggered lung aging. Both compounds are clinically tractable — NAC is already widely used and SS-31 is in clinical development.
Key caveats include the study's preclinical nature (mouse model and cell lines only), the use of acute rather than chronic ozone exposure, and that the full paper was not available for review — findings are based on the abstract alone.
Key Findings
- NAC and SS-31 equally reduced ozone-induced airway hyperresponsiveness and mucus overproduction in mice.
- Both antioxidants lowered mitochondrial ROS and restored key redox markers including SOD activity and GSH/GSSG ratio.
- Protective effects were mechanistically linked to suppression of PI3K/AKT and NLRP3/caspase-1 pyroptosis pathways.
- PI3K inhibition alone replicated the protective effects in human airway cells, confirming this as a key pathway.
- Mitochondria-targeted SS-31 matched broad antioxidant NAC, highlighting mitochondrial ROS as a viable therapeutic target.
Methodology
C57BL/6J mice received intraperitoneal NAC or SS-31 one hour before a single ozone exposure; airway function, inflammation, oxidative stress, and signaling pathways were assessed in vivo. Human bronchial epithelial cells (BEAS-2B) were used to confirm mechanistic findings in vitro, including a PI3K inhibitor control arm.
Study Limitations
This is a preclinical study using mice and cultured human cells, so clinical translation requires human trial confirmation. Only acute ozone exposure was modeled; chronic real-world pollution exposure dynamics are unknown. The summary is based on the abstract only, as the full paper was not available for review.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: